Provided by Tiger Trade Technology Pte. Ltd.

JACOBIO-B

6.230
-0.450-6.74%
Volume:4.11M
Turnover:25.79M
Market Cap:4.90B
PE:-29.06
High:6.800
Open:6.500
Low:6.150
Close:6.680
52wk High:11.800
52wk Low:2.350
Shares:786.00M
HK Float Shares:786.00M
Volume Ratio:1.63
T/O Rate:0.52%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.214
ROE:-17.24%
ROA:-7.80%
PB:5.59
PE(LYR):-29.06
PS:80.43

Loading ...

Jacobio-B (01167) FY2025: Loss Narrows to RMB146 Million as R&D Spend Falls 42.9%; Glecirasib Launch, Pan-KRAS Deal with AstraZeneca Highlight Pipeline Progress

Bulletin Express
·
Mar 10

Jacobio Pharmaceuticals FY2025 revenue fell 66% to CNY53.53 million

Reuters
·
Mar 10

Jacobio Pharmaceuticals Group FY Revenue RMB 53.5 Million

THOMSON REUTERS
·
Mar 10

Jacobio (01167) Announces Monthly Return for February 2026

Bulletin Express
·
Mar 02

Jacobio Pharmaceuticals (1167) Announces Board Meeting for Annual Results

Bulletin Express
·
Feb 26

Jacobio Pharmaceuticals schedules board meeting to approve annual results

Reuters
·
Feb 26

JACOBIO-B Shares Surge Over 6% in Afternoon Trading as Global Development of JAB-23E73 Accelerates

Stock News
·
Feb 06

Jacobio Pharmaceuticals (01167) Announces Monthly Securities Return for January 2026

Bulletin Express
·
Feb 05

One Jacobio Pharmaceuticals Group Insider Raised Their Stake In The Previous Year

Simply Wall St.
·
Jan 25

Jacobio-B (01167) Spends HK$965,500 to Repurchase 150,000 Shares on January 2

Stock News
·
Jan 02

HK Stock Movement | JACOBIO-B (01167) Rises Nearly 5% After Securing Nearly $2B Deal with AstraZeneca, Says Upfront Payment Above Average

Stock News
·
Dec 24, 2025

Stock Track | JACOBIO-B Plummets 12.58% Intraday After Selling JAB-23E73 License to AstraZeneca

Stock Track
·
Dec 22, 2025

AstraZeneca Joins the Fray: The Battle Over Pan-KRAS Inhibitor Technology Begins to Shift

Stock News
·
Dec 22, 2025

China Shenhua (01088) Launches 100 Billion Yuan Asset Restructuring; COMEX Silver Hits Record High

Stock News
·
Dec 22, 2025

Jacobio Pharma Enters Global Exclusive License Agreement With AstraZeneca for Pan-Kras Inhibitor Jab-23E73

THOMSON REUTERS
·
Dec 21, 2025

JACOBIO-B (01167) Subsidiary Enters Licensing Agreement with AstraZeneca to Develop and Commercialize Pan-KRAS Inhibitor JAB-23E73

Stock News
·
Dec 21, 2025

Jacobio Pharmaceuticals Partners with AstraZeneca on Pan-KRAS Inhibitor JAB-23E73

Reuters
·
Dec 21, 2025

HK Movers | Biomedical Stocks Jump With Xuanzhu Biopharmaceutical up 22%

Tiger Newspress
·
Dec 12, 2025

HK Stock Movement | JACOBIO-B (01167) Surges Over 11% Again After Receiving RMB125M Initial Payment from Oceanpine Capital

Stock News
·
Dec 10, 2025

Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Simply Wall St.
·
Dec 08, 2025